Patents by Inventor Lih-Chyang Chen

Lih-Chyang Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TP expression-inhibiting compound and siRNA sequence thereof
    Patent number: 8110675
    Abstract: The present invention discloses a TP expression-inhibiting compound and a TP expression-inhibiting siRNA sequence, wherein a siRNA sequence partially or completely complementary to the sequence of TP is used to inhibit TP expression, whereby is effectively reduced the survival rate of cancer cells in an anoxic environment.
    Type: Grant
    Filed: June 15, 2009
    Date of Patent: February 7, 2012
    Assignee: Chang Gung University
    Inventors: Lih-Chyang Chen, Yu-Sun Chang
  • hnRNP K expression-inhibiting compound and siRNA sequence thereof
    Patent number: 8013144
    Abstract: The present invention discloses an hnRNP K expression-inhibiting compound and a siRNA sequence thereof, wherein a siRNA sequence partially or completely complementary to the sequence of hnRNP K is used to inhibit hnRNP K expression, whereby is effectively reduced the survival rate of cancer cells in an anoxic environment.
    Type: Grant
    Filed: June 15, 2009
    Date of Patent: September 6, 2011
    Assignee: Chang Gung University
    Inventors: Lih-Chyang Chen, Yu-Sun Chang
  • Nasopharyngeal cancer malignancy biomarker and method thereof
    Publication number: 20100316996
    Abstract: The present invention discloses a nasopharyngeal cancer malignancy biomarker and a method thereof, wherein relative hnRNP K expression is used to evaluate the malignancy of nasopharyngeal cancer. The biomarker of the present invention assists the currently-existing inspections to find out cancer in the early stage and realize early diagnosis and early therapy. The present invention also functions as an effective indicator to monitor the metastasis and relapse of nasopharyngeal cancer.
    Type: Application
    Filed: June 15, 2009
    Publication date: December 16, 2010
    Inventors: Lih-Chyang Chen, Yu-Sun Chang
  • Nasopharyngeal cancer malingancy biomarker and method thereof
    Publication number: 20100317029
    Abstract: The present invention discloses a nasopharyngeal cancer malignancy biomarker and a method thereof, wherein relative TP expression is used to evaluate the malignancy of nasopharyngeal cancer. The biomarker of the present invention assists the currently-existing inspections to find out cancer in the early stage and achieve early diagnosis and early therapy. The present invention also functions as an effective indicator to monitor the metastasis and relapse of nasopharyngeal cancer.
    Type: Application
    Filed: June 15, 2009
    Publication date: December 16, 2010
    Inventors: Lih-Chyang Chen, Yu-Sun Chang
  • hnRNP K EXPRESSION-INHIBITING COMPOUND AND SIRNA SEQUENCE THEREOF
    Publication number: 20100317840
    Abstract: The present invention discloses an hnRNP K expression-inhibiting compound and a siRNA sequence thereof, wherein a siRNA sequence partially or completely complementary to the sequence of hnRNP K is used to inhibit hnRNP K expression, whereby is effectively reduced the survival rate of cancer cells in an anoxic environment.
    Type: Application
    Filed: June 15, 2009
    Publication date: December 16, 2010
    Inventors: Lih-Chyang CHEN, Yu-Sun CHANG
  • TP EXPRESSION-INHIBITING COMPOUND AND SIRNA SEQUENCE THEREOF
    Publication number: 20100317839
    Abstract: The present invention discloses a TP expression-inhibiting compound and a TP expression-inhibiting siRNA sequence, wherein a siRNA sequence partially or completely complementary to the sequence of TP is used to inhibit TP expression, whereby is effectively reduced the survival rate of cancer cells in an anoxic environment.
    Type: Application
    Filed: June 15, 2009
    Publication date: December 16, 2010
    Inventors: Lih-Chyang CHEN, Yu-Sun Chang